Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 15/20 | 0.52 |
| ▸ | CRBN | Q96SW2 | 15/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.42 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31356199 | 1.00 | DDB1 (0.52) | DDB1CRBNNPC1RAB9AMEN1 | |
| SCHEMBL31356172 | 0.90 | CRBN (0.65) | DDB1CRBN | |
| SCHEMBL31356217 | 0.90 | CRBN (0.65) | DDB1CRBN | |
| SCHEMBL31355909 | 0.90 | CRBN (0.65) | DDB1CRBN | |
| SCHEMBL31355921 | 0.90 | DDB1 (0.52) | DDB1CRBNNPC1RAB9A | |
| SCHEMBL31355948 | 0.89 | CRBN (0.52) | DDB1CRBN | |
| SCHEMBL31356012 | 0.89 | CRBN (0.52) | DDB1CRBN | |
| SCHEMBL31356053 | 0.85 | DDB1 (0.56) | DDB1CRBNNPC1RAB9AMEN1 | |
| SCHEMBL31356166 | 0.85 | DDB1 (0.56) | DDB1CRBNNPC1RAB9AMEN1 | |
| SCHEMBL31355972 | 0.80 | CRBN (0.55) | DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025026422-A1 | ARYL OR HETEROARYL SUBSTITUTED GLUTARIMIDE DERIVATIVE AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2025-02-06 | — | — | WO | claimed |